Adding etoposide to CHOP (CHOEP) improved the progression-free survival (PFS) in patients with peripheral T cell lymphoma, especially if ≤60 years old and in those with ALK+ ALCL (hazard ratio [HR] for ≤60 years old = 0.49, P=.008) (29, 30). The gene discussed is ALK; the disease is anaplastic large cell lymphoma.